Development of a rapid point-of-care diagnostic assay for differentiating bacterial versus viral etiologies in bovine mastitis using host-response biomarkers

Project Abstract

Bovine mastitis caused by bacterial and viral pathogens presents a significant challenge to dairy productivity and animal welfare, yet current diagnostic approaches often fail to rapidly distinguish etiologies at the point of care, leading to inappropriate antibiotic use and increased resistance. This study reports the development and validation of a rapid, point-of-care diagnostic assay that differentiates bacterial from viral etiologies in bovine mastitis by measuring host-response biomarkers in milk and serum within 30 minutes. We identified a panel of host-derived biomarkers—including acute phase proteins, cytokines, and pattern recognition receptor-related transcripts—through a combination of transcriptomic profiling and targeted proteomics in clinically diagnosed cases. A multi-analyte biosensor platform was engineered to detect a subset of these biomarkers with high sensitivity and specificity, leveraging microfluidic separation, immunoassay-based signal readouts, and a portable readout device compatible with field conditions on dairy farms. The assay workflow comprises sample collection, raw material processing, rapid biomarker interrogation, and on-site data interpretation with an embedded algorithm trained to classify etiology probability. The validation cohort included 600 lactating cows with clinical mastitis across multiple farms, representing diverse ages, lactation stages, and management practices, along with 200 healthy controls. Gold-standard diagnosis was established by a composite reference panel integrating bacterial culture, PCR-based pathogen detection, and serologic assays, supplemented by clinical grading. In the analytical phase, we employed machine learning models (random forest, support vector machine, and gradient boosting) to optimize the biomarker panel, achieving area under the receiver operating characteristic curves exceeding 0.92 for differentiating bacterial versus viral infection. The assay demonstrated a sensitivity of 0.89 and specificity of 0.93 in blinded validation, with a positive predictive value above 0.90 and a negative predictive value above 0.92 under practical prevalence scenarios. Robustness tests indicated stable performance across variable milk compositions, storage times, and minor hemolysis. A cost-effectiveness analysis suggested substantial reductions in unnecessary antibiotic use and associated residues, driven by rapid, etiologic guidance at the farm level. The device exhibited user-friendly operation, requiring minimal training, with results presented as a simple etiologic likelihood score and recommended treatment guidance. Secondary analyses explored correlations between host-response biomarker dynamics and clinical outcomes, including recovery time, milk production loss, and recurrence risk, offering potential prognostic utility. Ethical considerations included data privacy, animal welfare during sampling, and adherence to antimicrobial stewardship guidelines. The study integrates immunology, veterinary diagnostics, and bioengineering to deliver a practical tool for immediate decision-making in bovine mastitis management, aiming to improve therapeutic precision, reduce unnecessary antibiotic exposure, and enhance herd health and productivity. Future work will focus on expanding the biomarker panel to capture co-infections, validating across additional breeds and geographic regions, and integrating the platform with farm management software for seamless data capture and longitudinal monitoring.

Project Overview

What This Project Is About

---

A plain-language look at how scientists might quickly tell if mastitis in cows is caused by bacteria or viruses, using simple markers found in the animal’s body. The project combines biology and basic testing to create a fast, on-farm tool that helps farmers decide treatment sooner.

---

---

The Problem It Addresses

---

Mastitis is a common dairy cow problem that is often treated with antibiotics, even when the cause is viral and antibiotics won’t help. This leads to wasted drugs, higher costs, and potential antibiotic resistance. The project aims to reduce unnecessary antibiotic use by distinguishing bacterial from viral infections at the point of care.

---

---

Objectives of the Project

---

1. Identify practical host-response markers that differ between bacterial and viral mastitis.
2. Prototype a simple, rapid test that can be used on a farm or clinic.
3. Evaluate the test’s accuracy using samples from real cows with mastitis.
4. Assess how the test could fit into farm workflows and decision-making.
5. Discuss potential limitations and safety considerations for use in dairy herds.

---

---

What You Will Do Step by Step

---

1. Review existing literature on mastitis causes and host biomarkers.
2. Select a few promising biomarkers based on practicality and reliability.
3. Develop a simple assay design (e.g., a quick immuno-based test) and small-scale prototypes.
4. Collect milk or blood samples from cows with diagnosed mastitis cases.
5. Test samples with the prototype and compare results to standard lab tests.
6. Analyze data to measure accuracy, sensitivity, and specificity.
7. Refine the assay based on results and user feedback from potential end-users.
8. Prepare a short report on feasibility, costs, and deployment considerations.

---

---

Expected Outcome

A simple, rapid on-farm test that helps tell whether mastitis is bacterial or viral, enabling smarter treatment decisions and reducing unnecessary antibiotic use.